Acyline
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | MER-104 |
| Routes of administration |
Subcutaneous injection |
| Drug class | GnRH antagonist |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C80H102ClN15O14 |
| Molar mass | 1533.24 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Acyline (developmental code name MER-104) is a gonadotropin-releasing hormone analogue (GnRH analogue) and gonadotropin-releasing hormone antagonist (GnRH antagonist) which was never marketed. It has been shown to suppress gonadotropin and testosterone levels in men. Acyline is a peptide and under normal circumstances is not orally active. For this reason, it has instead been administered by subcutaneous injection.
See also
| GnRH |
|
||||
|---|---|---|---|---|---|
| Gonadotropin |
|
||||